基因Page:TF
概括?
基因ID | 7018 |
Symbol | TF |
同义词 | HEL-S-71p|PRO1557|PRO2086|TFQTL1 |
描述 | transferrin |
参考 | MIM:190000|HGNC:HGNC:11740|Ensembl:ENSG0000000091513|HPRD:01811|Vega:OTTHUMG00000150356 |
基因type | protein-coding |
地图位置 | 3q22.1 |
Pascal p-value | 0.351 |
Sherlock P值 | 0.241 |
Fetal beta | -3.71 |
eGene | 迈尔斯的顺式和跨性别 |
数据源中的基因
基因set name | 基因组方法 | 描述 | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
CV:PheWAS | 全球整个关联研究(PHEWAS) | 157 SNPs associated with schizophrenia | 1 |
PMID:cooccur | 高通量文献搜索 | Systematic search in PubMed for genes co-occurring with SCZ keywords. A total of 3027 genes were included. | |
Association | 组合的优势比方法(Sun et al. 2008),协会研究 | 1 | 链接到Szgene |
文学 | 高通量文献搜索 | Co-occurance with Schizophrenia keywords: schizophrenia,schizophrenic,schizophrenics,schizophrenias | Click to show details |
网络 | 人蛋白蛋白质相互作用网络中核心基因的最短路径距离 | Contribution to shortest path in PPI network: 0.0982 |
第一节遗传学和表观遗传学注释
CV:PheWAS
SNP ID | Chromosome | Position | Allele | P | Function | 基因 | Up/Down Distance |
---|---|---|---|---|---|---|---|
rs1867504 | 3 | 133410661 | null | 1.679 | TF | null |
eQTL annotation
SNP ID | Chromosome | Position | eGene | 基因Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
RS7830259 | chr8 | 14087643 | TF | 7018 | 0.19 | trans |
Section II. Transcriptome annotation
基因ral gene expression (GTEx)
基因expression during devlopment (BrainCloud)
脚注:
总共绘制了269个时间点,n = 38个胎儿样品(x = 1:38)。每个三角形代表一个时间点。
基因expression of temporal and spatial changes (BrainSpan)
脚注:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
基因 | Pearson's Correlation | Spearman's Correlation |
HADHB | 0.84 | 0.85 |
CYP2J2 | 0.84 | 0.85 |
HSPB8 | 0.82 | 0.86 |
CSRP1 | 0.81 | 0.83 |
SDC4 | 0.81 | 0.82 |
TMBIM1 | 0.80 | 0.86 |
CKMT2 | 0.80 | 0.75 |
EFEMP1 | 0.80 | 0.78 |
斯托姆 | 0.79 | 0.82 |
GRAMD3 | 0.79 | 0.84 |
Top 10 negatively co-expressed genes | ||
基因 | Pearson's Correlation | Spearman's Correlation |
NKIRAS2 | -0.58 | -0.55 |
CRMP1 | -0.57 | -0.57 |
Gprin1 | -0.57 | -0.58 |
ZNF821 | -0.56 | -0.56 |
C19orf57 | -0.56 | -0.57 |
NR2C2AP | -0.56 | -0.62 |
MPP3 | -0.56 | -0.58 |
AC011491.1 | -0.56 | -0.65 |
GMIP | -0.56 | -0.57 |
HN1 | -0.55 | -0.59 |
Section III. Gene Ontology annotation
Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
去:0008199 | ferric iron binding | IEA | - | |
GO:0046872 | 金属离子结合 | IEA | - | |
Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0006826 | iron ion transport | IEA | - | |
GO:0006811 | ion transport | IEA | - | |
GO:0006879 | cellular iron ion homeostasis | IEA | - | |
细胞分量 | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0005576 | extracellular region | IEA | - | |
GO:0005576 | extracellular region | NAS | 14718574 | |
GO:0005739 | mitochondrion | IDA | 18029348 | |
GO:0005768 | endosome | IEA | - | |
GO:0030139 | endocytic vesicle | IDA | 15229288|15292400 | |
GO:0030139 | endocytic vesicle | IEA | - |
第四节。蛋白质蛋白相互作用注释
Interactors | Aliases B | Official full name B | Experimental | 资源 | PubMed ID |
---|---|---|---|---|---|
CALR | CRT |FLJ26680 |ro |SSA |CC1QR | 钙网蛋白 | - | HPRD,Biogrid | 9312001 |
CANX | CNX | FLJ26570 | IP90 | P90 | calnexin | - | HPRD,Biogrid | 9312001 |
CUBN | FLJ90055 |FLJ90747 |ifcr |MGA1 |GP280 | cubilin(内在factor-cobalamin受体) | Transferrin interacts with Cubilin. | BIND | 11606717 |
FNBP1 | FBP17 |KIAA0554 |MGC126804 | formin binding protein 1 | Co-localization | BioGRID | 15252009 |
IGF1 | IGFI | insulin-like growth factor 1 (somatomedin C) | Reconstituted Complex | BioGRID | 11749962 |
IGF2 | C11orf43 | FLJ22066 | FLJ44734 | INSIGF | pp9974 | insulin-like growth factor 2 (somatomedin A) | Reconstituted Complex | BioGRID | 11749962 |
IGFBP1 | AFBP | IBP1 | IGF-BP25 | PP12 | hIGFBP-1 | insulin-like growth factor binding protein 1 | - | HPRD | 11297622 |
IGFBP2 | IBP2 | IGF-BP53 | insulin-like growth factor binding protein 2, 36kDa | - | HPRD | 11297622 |
IGFBP3 | BP-53 | IBP3 | insulin-like growth factor binding protein 3 | - | HPRD,Biogrid | 11297622|11749962 |
IGFBP4 | BP-4 |HT29-IGFBP |IBP4 |IGFBP-4 | insulin-like growth factor binding protein 4 | - | HPRD | 11297622 |
IGFBP5 | IBP5 | insulin-like growth factor binding protein 5 | - | HPRD | 11297622 |
IGFBP6 | IBP6 | insulin-like growth factor binding protein 6 | - | HPRD | 11297622 |
TFR2 | HFE3 | MGC126368 | TFRC2 | transferrin receptor 2 | - | HPRD,Biogrid | 11027676 |
TFRC | CD71 | TFR | TFR1 | TRFR | transferrin receptor (p90, CD71) | TF与TFR相互作用。 | BIND | 15525538 |
TFRC | CD71 | TFR | TFR1 | TRFR | transferrin receptor (p90, CD71) | Reconstituted Complex | BioGRID | 11027676 |
TFRC | CD71 | TFR | TFR1 | TRFR | transferrin receptor (p90, CD71) | - | HPRD | 6268632 |
TUBB3 | MC1R | TUBB4 | beta-4 | tubulin, beta 3 | 两个杂交 | BioGRID | 16169070 |
V.途径注释
Pathway name | Pathway size | #szgr 2.0基因 | Info |
---|---|---|---|
ST WNT CA2 CYCLIC GMP PATHWAY | 20 | 14 | 该途径中的所有SZGR 2.0基因 |
PID EPHB FWD PATHWAY | 40 | 38 | 该途径中的所有SZGR 2.0基因 |
PID HIF1 TFPATHWAY | 66 | 52 | 该途径中的所有SZGR 2.0基因 |
对血小板胞质CA2升高的反应组反应 | 89 | 56 | 该途径中的所有SZGR 2.0基因 |
REACTOME TRANSMEMBRANE TRANSPORT OF SMALL MOLECULES | 413 | 270 | 该途径中的所有SZGR 2.0基因 |
REACTOME IRON UPTAKE AND TRANSPORT | 36 | 18 | 该途径中的所有SZGR 2.0基因 |
REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | 25 | 10 | 该途径中的所有SZGR 2.0基因 |
REACTOME HEMOSTASIS | 466 | 331 | 该途径中的所有SZGR 2.0基因 |
REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | 208 | 138 | 该途径中的所有SZGR 2.0基因 |
家长mtor信号向上 | 567 | 375 | 该途径中的所有SZGR 2.0基因 |
SENGUPTA NASOPHARYNGEAL CARCINOMA WITH LMP1 DN | 175 | 82 | 该途径中的所有SZGR 2.0基因 |
TURASHVILI BREAST DUCTAL CARCINOMA VS DUCTAL NORMAL DN | 198 | 110 | 该途径中的所有SZGR 2.0基因 |
GRAESSMANN APOPTOSIS BY DOXORUBICIN DN | 1781年 | 1082 | 该途径中的所有SZGR 2.0基因 |
HATADA METHYLATED IN LUNG CANCER UP | 390 | 236 | 该途径中的所有SZGR 2.0基因 |
MANTOVANI VIRAL GPCR SIGNALING DN | 49 | 37 | 该途径中的所有SZGR 2.0基因 |
BERTUCCI INVASIVE CARCINOMA DUCTAL VS LOBULAR DN | 46 | 34 | 该途径中的所有SZGR 2.0基因 |
RICKMAN HEAD AND NECK CANCER D | 37 | 14 | 该途径中的所有SZGR 2.0基因 |
Colin Pilocytic星形胶质细胞瘤与胶质母细胞瘤UP | 35 | 32 | 该途径中的所有SZGR 2.0基因 |
SHEN SMARCA2 TARGETS DN | 357 | 212 | 该途径中的所有SZGR 2.0基因 |
CERVERA SDHB TARGETS 2 | 114 | 76 | 该途径中的所有SZGR 2.0基因 |
ASTON MAJOR DEPRESSIVE DISORDER DN | 160 | 110 | 该途径中的所有SZGR 2.0基因 |
松本自然杀手差分 | 475 | 313 | 该途径中的所有SZGR 2.0基因 |
HSIAO肝特异性基因 | 244 | 154 | 该途径中的所有SZGR 2.0基因 |
BROWN MYELOID CELL DEVELOPMENT DN | 129 | 86 | 该途径中的所有SZGR 2.0基因 |
HESS TARGETS OF HOXA9 AND MEIS1 DN | 77 | 48 | 该途径中的所有SZGR 2.0基因 |
HARRIS HYPOXIA | 81 | 64 | 该途径中的所有SZGR 2.0基因 |
BLALOCK ALZHEIMERS DISEASE UP | 1691年 | 1088 | 该途径中的所有SZGR 2.0基因 |
Semenza HIF1目标 | 36 | 32 | 该途径中的所有SZGR 2.0基因 |
WANG CISPLATIN RESPONSE AND XPC UP | 202 | 115 | 该途径中的所有SZGR 2.0基因 |
CHENG RESPONSE TO NICKEL ACETATE | 45 | 29 | 该途径中的所有SZGR 2.0基因 |
ZHONG SECRETOME OF LUNG CANCER AND ENDOTHELIUM | 66 | 47 | 该途径中的所有SZGR 2.0基因 |
ZHONG SECRETOME OF LUNG CANCER AND FIBROBLAST | 132 | 93 | 该途径中的所有SZGR 2.0基因 |
MARTINEZ RB1 TARGETS UP | 673 | 430 | 该途径中的所有SZGR 2.0基因 |
MARTINEZ TP53 TARGETS UP | 602 | 364 | 该途径中的所有SZGR 2.0基因 |
MARTINEZ RB1 AND TP53 TARGETS UP | 601 | 369 | 该途径中的所有SZGR 2.0基因 |
SMID BREAST CANCER NORMAL LIKE UP | 476 | 285 | 该途径中的所有SZGR 2.0基因 |
CADWELL ATG16L1 TARGETS UP | 93 | 56 | 该途径中的所有SZGR 2.0基因 |
BREDEMEYER RAG SIGNALING NOT VIA ATM DN | 57 | 34 | 该途径中的所有SZGR 2.0基因 |
WINTER HYPOXIA METAGENE | 242 | 168 | 该途径中的所有SZGR 2.0基因 |
Yoshimura mapk8靶向 | 1305 | 895 | 该途径中的所有SZGR 2.0基因 |
Poola侵入性乳腺癌DN | 134 | 83 | 该途径中的所有SZGR 2.0基因 |
BOYAULT LIVER CANCER SUBCLASS G3 DN | 51 | 32 | 该途径中的所有SZGR 2.0基因 |
LI INDUCED T TO NATURAL KILLER UP | 307 | 182 | 该途径中的所有SZGR 2.0基因 |
CHYLA CBFA2T3 TARGETS UP | 387 | 225 | 该途径中的所有SZGR 2.0基因 |
PILON KLF1 TARGETS UP | 504 | 321 | 该途径中的所有SZGR 2.0基因 |
VANDESLUIS COMMD1 TARGETS GROUP 3 UP | 89 | 50 | 该途径中的所有SZGR 2.0基因 |
YANG BCL3 TARGETS UP | 364 | 236 | 该途径中的所有SZGR 2.0基因 |